FOCAL ONSET SEIZURE
Clinical trials for FOCAL ONSET SEIZURE explained in plain language.
Never miss a new study
Get alerted when new FOCAL ONSET SEIZURE trials appear
Sign up with your email to follow new studies for FOCAL ONSET SEIZURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New epilepsy drug tested as standalone treatment
Disease control OngoingThis study tests whether cenobamate, already approved for epilepsy, works well when used alone in adults with partial-onset seizures. About 49 participants will take either 100 mg or 200 mg daily, and researchers will track how many become seizure-free for 26 weeks. The goal is t…
Matched conditions: FOCAL ONSET SEIZURE
Phase: PHASE4 • Sponsor: SK Life Science, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for epilepsy: Real-World data on Cenobamate's impact
Disease control OngoingThis study looks at how well the drug cenobamate works for adults with focal seizures that don't improve with at least two other epilepsy medicines. Researchers are collecting data from Italian clinics and a compassionate use program to measure seizure reduction and side effects.…
Matched conditions: FOCAL ONSET SEIZURE
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Disease control
Last updated Jun 26, 2026 15:21 UTC